{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-016244","form_type":"8-K","ticker":null,"cik":"0000799698","company_name":"LadRx Corp","filed_at":"2023-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.265961+00:00","generated_at":"2026-06-15T05:17:24.989223+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"LadRx to effect 1-for-100 reverse stock split on May 17, 2023 to support strategic review","bullets":["Reverse split ratio 1-for-100, effective 5:00 a.m. PDT on May 17, 2023; trading begins split-adjusted May 18.","Outstanding shares reduced from 46,587,391 to approximately 465,587; no change in authorized shares (62,393,940).","Fractional shares rounded up to next whole share; no fractional shares issued.","New CUSIP number 232828608; trading symbol LADX unchanged on OTC Markets.","Split intended to facilitate strategic alternatives including possible up-listing to Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-016244","json":"https://secwatch.observer/filing/0001493152-23-016244.json","markdown":"https://secwatch.observer/filing/0001493152-23-016244.md","text":"https://secwatch.observer/filing/0001493152-23-016244.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/799698/000149315223016244/0001493152-23-016244-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/799698/000149315223016244/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T05:17:24.989223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1225d3893bb3146c172650025d74150bc3cd96fa","claim":"LadRx Corp: Filed Certificate of Amendment to effect 1-for-100 reverse stock split (effective 2023-05-17).","evidence_excerpt":"On May 9, 2023, LadRx Corporation (the “Company”) filed a Certificate of Amendment of Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect a 1-for-100 reverse stock split of the shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), either issued and outstanding or held by the Company as treasury stock, effective as of 5:00 a.m. (Pacific time) on May 17, 2023 (the “Reverse Stock Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/799698/000149315223016244/0001493152-23-016244-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-05-17"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}